Science Board Accepts Global Health Subcommittee Report, Advises Office of Women’s Health
This article was originally published in The Gray Sheet
Executive Summary
Global Health subcommittee presents FDA Science Board with a report of its findings, and the Office of Women’s Health solicits advice on its research roadmap.
You may also be interested in...
Device Center Moves To Better Prioritize Its Scientific Work
CDRH Director Jeffrey Shuren says the center is taking multiple steps, including the creation of a new internal subcommittee and possible restructuring to its research offices, in response to critiques from the FDA Science Board on how well CDRH is accomplishing its scientific mission.
FDA Global Health Subcommittee Will Focus On Regulatory Systems In Developing Countries
An FDA Science Board subcommittee will look for ways to strengthen regulatory systems in emerging economies.
New Subcommittee To Look Afresh At FDA Regulatory Science Needs
FDA's Science Board will create a new subcommittee to provide guidance on regulatory science needs in a “rapidly changing future,” according to FDA Chief Scientist Jesse Goodman.